Evidence map›Paper›PMID 40761660›Full record

ArticleMediators of inflammation2025

Determination of Serum Alpha-1-Acid Glycoprotein Concentration and the Influence of Physiological and Gynecological Factors in Women Attending in Tertiary-Care Center in Mexico: A Pilot Study.

Liliana García-Ortiz, Mariana Téllez-Araiza, José Gutiérrez-Salinas, Liliana Hernández-Figueroa, Juana Arellano-García, Erasmo Cordero-Martínez

Abstract read
In one paragraph

Article in Mediators of inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liliana García-OrtizSchool of Medicine, Postgraduate Department, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.ORCID https://orcid.org/0000-0003-1629-6128
Mariana Téllez-AraizaLaboratory of Immunopharmacology, National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
José Gutiérrez-SalinasLaboratory of Biochemistry and Experimental Medicine, Division of Biomedical Research, National Medical Center "20 Noviembre", ISSSTE, Mexico City, Mexico.
Liliana Hernández-FigueroaClinical Laboratory, National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
Juana Arellano-GarcíaLaboratory of Immunopharmacology, National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
Erasmo Cordero-MartínezResearch Unit, National Institute of Respiratory Diseases (INER), Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha 1-acid glycoprotein (AGP1) is recognized as a protein with an important immunomodulatory activity, which under certain circumstances its serum concentration is altered as a result of acute metabolic stress (e.g., infections) or chronic (e.g., obesity). This quality of altering its concentration according to the immunological circumstances of the individuals, for example, in women, in which hormonal variables, nutritional states, and/or pregnancy, has led to think that one protein can be used as a biomarker in cancer, immunological diseases, and other pathologies. The aim of the present study was to determine the concentration of AGP1 protein in serum samples of apparently healthy women and to associate this concentration with several variables, such as age, body weight, and other physiological variables, that may affect the concentration of this protein. A total of 656 apparently healthy women were included according to their clinical history, physical examination, and laboratory tests. The determination of AGP1 concentration was performed by nephelometry in serum samples. The results show that the overall mean serum concentration of AGP1 was 76.82 ± 18.63 mg/dL (range 37.95-175 mg/dL). This concentration is observed to be altered in women who presented morbid obesity (83.79 mg/dL;

Indexed as

OrosomucoidAdolescentAdultAgedBiomarkersFemaleHumansMexicoMiddle AgedObesity, MorbidPilot ProjectsPregnancyTertiary Care CentersYoung AdultBiomarkersOrosomucoid

Identifiers

PMID40761660
PMCPMC12321414

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.